Informatie:
Fout:
ID
35832
Beschrijving
Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (SADAL); ODM derived from: https://clinicaltrials.gov/show/NCT02227251
Link
https://clinicaltrials.gov/show/NCT02227251
Trefwoorden
Versies (1)
- 26-03-19 26-03-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
26 maart 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diffuse Large B-cell Lymphoma NCT02227251
Eligibility Diffuse Large B-cell Lymphoma NCT02227251
- StudyEvent: Eligibility
Similar models
Eligibility Diffuse Large B-cell Lymphoma NCT02227251
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Age
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of ≤ 2
boolean
C1520224 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma de novo
Item
pathologically confirmed de novo dlbcl
boolean
C0079744 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
C1515568 (UMLS CUI [1,2])
Disease Progression
Item
objective, documented evidence of disease progression on study entry
boolean
C0242656 (UMLS CUI [1])
Chemotherapy multiple agents systemic Quantity Diffuse Large B-Cell Lymphoma
Item
have previously received at least 2 but no more than 4 previous systemic multi-agent regimens for the treatment of dlbcl
boolean
C0854615 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0079744 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0079744 (UMLS CUI [1,3])
Measurable Disease
Item
have measurable disease
boolean
C1513041 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma | Histology Other
Item
dlbcl with coexistent histologies
boolean
C0079744 (UMLS CUI [1])
C0344441 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0344441 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Therapy High dose Autologous Stem Cell Rescue
Item
must not be eligible for high-dose therapy with autologous stem cell transplantation rescue
boolean
C0087111 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C2825926 (UMLS CUI [1,3])
C0444956 (UMLS CUI [1,2])
C2825926 (UMLS CUI [1,3])
Mediastinal (Thymic) Large B-Cell Lymphoma
Item
primary mediastinal (thymic) large b-cell lymphoma (pmbl)
boolean
C1292754 (UMLS CUI [1])
Central nervous system lymphoma
Item
known central nervous system (cns) lymphoma
boolean
C0742472 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
active hepatitis b or c infection
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019196 (UMLS CUI [2])
HIV Infection
Item
known human immunodeficiency virus (hiv) infection
boolean
C0019693 (UMLS CUI [1])
Lacking Able to swallow Tablets | Malabsorption Syndrome | Gastrointestinal Disease Interferes with Absorption Investigational New Drugs | Gastrointestinal function Interferes with Absorption Investigational New Drugs
Item
unable to swallow tablets, patients with malabsorption syndrome, or any other gi disease or gi function that could interfere with absorption of study treatment
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
C0024523 (UMLS CUI [2])
C0017178 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0237442 (UMLS CUI [3,3])
C0013230 (UMLS CUI [3,4])
C0516983 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0237442 (UMLS CUI [4,3])
C0013230 (UMLS CUI [4,4])
C2712086 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,3])
C0024523 (UMLS CUI [2])
C0017178 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0237442 (UMLS CUI [3,3])
C0013230 (UMLS CUI [3,4])
C0516983 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0237442 (UMLS CUI [4,3])
C0013230 (UMLS CUI [4,4])